Top Industry News

Vertex Pharmaceuticals, a Boston-based bio/pharmaceutical company, has agreed to acquire Alpine Immune Sciences, a Seattle, Washington-based clinical-stage bio/pharmaceutical company developing protein-based immunotherapies, for approximately $4.9 billion.  Alpine’s lead molecule, povetacicept…

Moderna, a Cambridge, Massachusetts-based bio/pharmaceutical company, and Blackstone, an investment-management firm, have announced a new collaboration under which Blackstone will provide up to $750 million to fund Moderna’s influenza program. …

The latest from CDMOs, CMOs, and suppliers featuring Euroapi, MilliporeSigma, Schott Pharma, CoreRx and AustinPx.   Chemicals/Chemical API Manufacturing * Euroapi Reorganizes Executive Leadership Biologics Manufacturing * MilliporeSigma Investing $326 M in Biologic Mfg…

A roundup of bio/pharmaceutical partnering news from Gilead Sciences/Nurix Therapeutics, Merck KGaA/Caris Discovery, Novartis/Arvinas and Teva/mAbXience.  * Gilead, Nurix Therapeutics Extend $1.8-Bn Research Pact* Merck KGaA, Caris in $1.4-Bn ADC…

A roundup of manufacturing news from Novartis and Novo Nordisk/Ginkgo. Highlights below.  * Novartis To Implement Mfg Changes for Breast Cancer Drug Candidate due to Nitrosamine Impurities * Novo Nordisk, Ginkgo…

A roundup of news from Johnson & Johnson. Highlights below.   * J&J To Acquire Shockwave Medical for $13.1 Bn  J&J To Acquire Shockwave Medical for $13.1 Bn Johnson & Johnson (J&J)…

Lonza has named Wolfgang Wienand, currently CEO of Siegfried Holding AG,  a CDMO of drug substances and drug products, as CEO. Wienand will join Lonza during the summer of 2024.…

Recipharm, a CDMO of drug substances and drug products, reports that Blue Wolf Capital Partners, a US-based private equity firm, has committed, subject to regulatory clearances, to acquire seven of its…

Genmab, a Copenhagen, Denmark-based bio/pharmaceutical company, has agreed to acquire ProfoundBio, a Seattle, Washington-based bio/pharmaceutical company, for $1.8 billion.   ProfoundBio is a privately owned clinical-stage biotechnology company developing antibody drug…

Bora Pharmaceuticals, a Taipei City, Taiwan-based pharmaceutical company and CDMO of drug products, has completed its acquisition of Upsher-Smith Laboratories, a pharmaceutical company focused on specialty brands and generics, for…